Michał Mielcarek

HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration

Michał Mielcarek, Christian Landles, Andreas Weiss et al. · PLoS Biology · 2013 · 170 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease

Michał Mielcarek, Caroline Benn, Sophie Franklin et al. · PLoS ONE · 2011 · 162 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +16

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease

Michał Mielcarek, Linda Inuabasi, Marie K. Bondulich et al. · PLoS Genetics · 2014 · 93 citations · Full text

Life Sciences, Cardiology, Neurology +17

Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model

Michał Mielcarek, Ryszard T. Smoleński, Mark Isalan · Frontiers in Physiology · 2017 · 70 citations · Full text

Life Sciences, Genetics, Neurology +17

Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease

Caroline Benn, Rachel Butler, Lydia Mariner et al. · PLoS ONE · 2009 · 65 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17